Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells : Dual interference of this loop more effectively impairs melanoma cell invasion

In English

Författare

  • Rickard Linnskog
  • Purusottam Mohapatra
  • Farnaz Moradi
  • Chandra Prakash Prasad
  • Tommy Andersson

Summary, in English

Increased expression and signalling of WNT5A and interleukin-6 (IL-6) have both been shown to promote melanoma progression. Here, we investigated the proposed existence of a WNT5A-IL-6 positive feedback loop that drives melanoma migration and invasion. First, the HOPP algorithm revealed that the invasive phenotype of cultured melanoma cells was significantly correlated with increased expression of WNT5A or IL-6. In three invasive melanoma cell lines, endogenous WNT5A protein expression was related to IL-6 protein secretion. Knockdown with anti-IL-6 siRNAs or treating WM852 melanoma cells with a neutralising anti-IL-6 antibody reduced WNT5A protein expression. Conversely, the silencing of WNT5A expression by WNT5A siRNAs or treating WM852 melanoma cells with Box5 (a WNT5A antagonist) significantly reduced IL-6 secretion. Interestingly, these effects occurred at the protein level but not at the transcriptional levels. Functionally, we demonstrated that combined siRNA knockdown of WNT5A and IL-6 expression or the simultaneous inhibition of WNT5A and IL-6 signalling inhibited melanoma cell invasion more effectively than suppressing each factor individually. Together, our results demonstrate that WNT5A and IL-6 are connected through a positive feedback loop in melanoma cells and that the combined targeting of both molecules could serve as an effective therapeutic means to reduce melanoma metastasis.

Avdelning/ar

Publiceringsår

2016

Språk

Engelska

Sidor

37790-37802

Publikation/Tidskrift/Serie

Oncotarget

Volym

7

Issue

25

Dokumenttyp

Artikel i tidskrift

Förlag

Impact Journals

Ämne

  • Basic Medicine

Nyckelord

  • Anti-IL-6-Ab
  • Box5
  • Interleukin-6
  • Melanoma invasion
  • WNT5A

Status

Published

Forskningsgrupp

  • Experimental Cancer Research, Malmö
  • Experimental Pathology, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1949-2553